160 related articles for article (PubMed ID: 37415983)
1. A promising self-nanoemulsifying adjuvant with plant-derived saponin D boosts immune response and exerts an anti-tumor effect.
Luo X; Song Z; Zeng X; Ye Y; Zheng H; Cai D; Yuan Q; Li H; Tong Y; Lu D; Liu Y; Zeng H; Yang Y; Sun H; Zou Q
Front Immunol; 2023; 14():1154836. PubMed ID: 37415983
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection.
Sun H; He S; Shi M
Int Immunopharmacol; 2014 Oct; 22(2):346-55. PubMed ID: 25075718
[TBL] [Abstract][Full Text] [Related]
3. An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy.
Tong YN; Yang LY; Yang Y; Song Z; Peng LS; Gao JN; Zeng H; Zou QM; Sun HW; Mao XH
Acta Biomater; 2018 Sep; 77():255-267. PubMed ID: 30031164
[TBL] [Abstract][Full Text] [Related]
4. IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice.
Cibulski S; Teixeira TF; Varela APM; de Lima MF; Casanova G; Nascimento YM; Fechine Tavares J; da Silva MS; Sesterheim P; Souza DO; Roehe PM; Silveira F
Vaccine; 2021 Jan; 39(3):571-579. PubMed ID: 33339669
[TBL] [Abstract][Full Text] [Related]
5. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Xie Y; Sun HX; Li D
Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
[TBL] [Abstract][Full Text] [Related]
6. Silk Fibroin Nanoadjuvant as a Promising Vaccine Carrier to Deliver the FimH-IutA Antigen for Urinary Tract Infection.
Hasanzadeh S; Farokhi M; Habibi M; Shokrgozar MA; Ahangari Cohan R; Rezaei F; Asadi Karam MR; Bouzari S
ACS Biomater Sci Eng; 2020 Aug; 6(8):4573-4582. PubMed ID: 33455198
[TBL] [Abstract][Full Text] [Related]
7. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.
Okazaki S; Iwasaki T; Yuba E; Watarai S
J Vet Med Sci; 2018 Feb; 80(2):197-204. PubMed ID: 29311431
[TBL] [Abstract][Full Text] [Related]
9. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
[TBL] [Abstract][Full Text] [Related]
10. Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.
Sun H; Fei L; Zhu B; Shi M
BMC Vet Res; 2020 Nov; 16(1):427. PubMed ID: 33160337
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum.
Xie Y; Ye YP; Sun HX; Li D
Vaccine; 2008 Jun; 26(27-28):3452-60. PubMed ID: 18501482
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of immune responses using ovalbumin-conjugated Eucommia ulmoides leaf polysaccharides encapsulated in a cubic liquid-crystalline phase delivery system.
Feng H; Zhang L; Yang J; Li S; Tang F; Li H; Zhang X; Wu D; Feng Y; Liu Q; Liu Z
J Sci Food Agric; 2022 Nov; 102(14):6757-6770. PubMed ID: 35638143
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses.
Kumar S; Kesharwani SS; Kuppast B; Bakkari MA; Tummala H
J Control Release; 2017 Sep; 261():263-274. PubMed ID: 28669593
[TBL] [Abstract][Full Text] [Related]
15. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration.
Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z
Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271
[TBL] [Abstract][Full Text] [Related]
17. Platycodin d improves the immunogenicity of newcastle disease virus-based recombinant avian influenza vaccine in mice.
Xie Y; Sun HX; Li D
Chem Biodivers; 2010 Mar; 7(3):677-89. PubMed ID: 20232336
[TBL] [Abstract][Full Text] [Related]
18. Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses.
de Costa F; Yendo AC; Cibulski SP; Fleck JD; Roehe PM; Spilki FR; Gosmann G; Fett-Neto AG
PLoS One; 2014; 9(8):e105374. PubMed ID: 25148077
[TBL] [Abstract][Full Text] [Related]
19. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
20. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
